AMP |
adenosin monophosphate |
ATP |
adenosintriphosphat |
CLD7 |
Claudin 7 |
CSS |
cancer-specific survival |
ccRCC |
clear cell renal cell carcinoma |
chRCC |
chromophobe renal cell carcinoma |
cGAMP |
cyclic guanosine monophosphate-adenosin monophosphate |
cGMP |
cyclic Guanosinmonophosphate |
cGAS |
cyclic guanosine monophosphate-adenosin monophosphate synthase |
CTLA-4 |
cytotoxic T-lymphocyte-associated protein 4 |
FFPE |
formalin-fixed paraffin-embedded |
FT-ICR |
Fourier-transform ion cyclotron resonance |
GMP |
guanosin monophosphate |
GTP |
guanosintriphosphate |
IFN |
interferon |
IkB or IKK |
IkappaB kinase |
IRF3 |
interferon regulatory factor 3 |
ISUP |
International Society of Urological Pathology |
KM |
Kaplan–Meier |
MALDI |
High mass resolution matrix-assisted laser desorption/ionization |
MET |
mesenchymal–epithelial transition factor |
MSI |
mass spectrometry imaging |
NF-κB |
nuclear factor kappa B |
OS |
overall survival |
PD-1 |
programmed death 1 |
PD-L1 |
programmed Death-Ligand 1 |
pRCC |
papillary renal cell carcinoma |
PFS |
progression free survival |
RMC |
renal medullary carcinoma |
rO |
renal oncocytoma |
STING |
stimulator of interferon genes |
TBK1 |
Tank-binding kinase 1 |
TNFα |
tumor necrosis factor α |
TMA |
tissue microarray |
WHO |
World Health Organization |